Old diuretic drug shows promise for Autism-Linked gene condition
NCT ID NCT06678685
First seen Mar 23, 2026 · Last updated May 10, 2026 · Updated 7 times
Summary
This study tested spironolactone, a common diuretic, in 2 children aged 3-10 with NCOR gene mutations and autism. The goal was to see if it could improve learning, memory, and autism symptoms. The drug is already known to be safe in children for other uses.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Qilu Hospital of Shandong University
Jinan, Shandong, 250012, China
Conditions
Explore the condition pages connected to this study.